• Proteinase K: Translational Control of Proteolysis

  2026-09-21

  Proteinase K is more than a routine digestion reagent. Its broad substrate tolerance, inhibitor resistance, and compatibility with demanding buffer conditions make it a strategic tool for high-integrity DNA workflows and for designing better protease selectivity controls. This article connects molecular mechanism, assay validation, and translational decision-making without confusing broad protein hydrolysis with target-specific inhibition.

• Nonivamide: TRPV1 Workflows for Cancer Research

  2026-09-21

  Nonivamide combines selective TRPV1 activation with reported cancer cell growth inhibition, making it useful for parallel oncology and neuroimmune assays. This guide translates the evidence into practical stock preparation, cell-based apoptosis workflows, inflammation-focused experiments, and troubleshooting decisions.

• UBR1 and UBR2 in ER Stress Protein Quality Control

  2026-09-20

  The reference study identifies the N-recognin E3 ligases UBR1 and UBR2 as stress-responsive regulators of mammalian protein quality control. Its findings connect their stress-dependent stabilization and proteasome-linked turnover with protection against endoplasmic reticulum stress-induced apoptosis, highlighting a previously underappreciated role for the N-degron pathway in ER-associated degradation.

• 10 mM dNTP Mixture for LNP Assays

  2026-09-19

  Use a defined 10 mM dNTP mixture to standardize PCR, qPCR, sequencing, and DNA payload measurements around lipid nanoparticle studies. The workflow separates nucleotide quality from LNP biology, helping researchers interpret how particle charge and cellular V-ATPase activity influence delivery.

• Safe DNA Gel Stain for Safer Gel Imaging

  2026-09-18

  Safe DNA Gel Stain supports sensitive DNA and RNA visualization while replacing routine ethidium bromide and UV exposure with a blue-light-compatible workflow. Its in-gel and post-electrophoresis formats are useful for cloning, fragment recovery, RNA checks, and reproducible molecular biology nucleic acid detection.

• Vincristine Sulfate: From Binding to Cell Fate

  2026-09-18

  Explore how vincristine sulfate connects tubulin engagement with interpretable cancer research outcomes. This guide combines molecular pharmacology, assay design, product handling, and evidence-triage principles for studying microtubule dynamics.

• Hexamethonium Bromide: Causal Autonomic Assays

  2026-09-17

  Hexamethonium Bromide enables controlled interrogation of autonomic ganglia and nicotinic acetylcholine receptor signaling. This article explains how to use ganglionic blockade to distinguish sympathetic contributions from broader blood-pressure phenotypes, with special attention to sex-dependent angiotensin II hypertension models.

• Dabigatran Etexilate: Oral Direct Thrombin Inhibition

  2026-09-17

  The reference paper provides an integrated clinical pharmacology review of dabigatran etexilate as the first marketed oral direct thrombin inhibitor in the United States. Its central contribution is to connect prodrug activation, predictable pharmacokinetics, clinical efficacy, renal handling, bleeding risk, and therapeutic positioning across venous thromboembolism and nonvalvular atrial fibrillation.

• Capsaicin as a KDM1A/LSD1 Inhibitor

  2026-09-16

  The reference study identifies capsaicin, or (E)-Capsaicin, as a direct, reversible, FAD-competitive inhibitor of KDM1A/LSD1. Its biochemical activity was connected to reduced gastric cancer cell migration and invasion through epithelial–mesenchymal transition, providing a mechanistic link between a dietary natural product and histone methylation biology.

• Capsaicin: From TRPV1 to Epigenetic Translation

  2026-09-16

  Capsaicin is more than a sensory-neuron probe. Its established TRPV1 ion channel activation profile now sits alongside evidence for reversible KDM1A/LSD1 inhibition, creating a valuable but challenging translational model spanning pain signaling, inflammation signaling, and gastric cancer biology. This article outlines how to validate the dual mechanism, manage assay confounding, and design more informative workflows with (E)-Capsaicin.

• Hexamethonium Bromide for Autonomic Research

  2026-09-15

  Hexamethonium Bromide enables controlled interrogation of autonomic ganglionic transmission rather than relying on blood pressure changes alone. This practical guide connects fresh-solution handling, conscious telemetry, sex-aware hypertension models, and troubleshooting for more interpretable neuronal signaling experiments.

• 3D Organoid-Fibroblast Models of PDAC Chemoresistance

  2026-09-15

  Schuth et al. developed a patient-matched three-dimensional co-culture system that combines pancreatic ductal adenocarcinoma organoids with cancer-associated fibroblasts. The model showed that stromal fibroblasts increase organoid proliferation, reduce chemotherapy-induced cell death, and promote transcriptional programs associated with epithelial-to-mesenchymal transition, providing a more biologically complete framework for personalized drug-response studies.

• OPP: Reading Translation in Stressed B Cells

  2026-09-14

  O-propargyl-puromycin (OPP) offers a direct way to quantify nascent protein production when mitochondrial dysfunction reshapes B-cell behavior. This article connects OPP assay design with the Pcbp1-Fdxr mechanism while emphasizing controls, interpretation, and experimental limitations.

• Anti-ROR1 Antibody: Assay Design Beyond Pathways

  2026-09-14

  Anti-ROR1 Antibody (Zilovertamab) can strengthen ROR1 target-validation workflows when its role is separated from direct toxicology readouts. This article connects product-specific assay planning with mechanistic lessons from deoxynivalenol-induced liver injury while defining the evidence limits of that cross-domain application.

• 20-HETE–TRPV1 Signaling in Chronic Dermatitis

  2026-09-13

  The reference study identifies a peripheral mechanism by which chronic dermatitis converts normally painful capsaicin responses into itch: elevated 20-HETE activates TRPV1 on sensitized MrgprA3+ sensory neurons. Its combination of behavioral, genetic, electrophysiological, metabolomic, and pharmacological evidence links lipid metabolism to allokinesis and suggests that 20-HETE–TRPV1–MrgprA3 signaling is a tractable pathway for studying chronic itch.

8087 records 1/540 page Next 12345 下5页 Last page